Dr. Mark McKenna’s Commitment to Community Wellness

A graduate of Tulane University Medical School, Dr. Mark McKenna is a licensed surgeon and a compassionate patient advocate. Shortly after completing medical school, he got his first taste of entrepreneurship while practicing medicine with his father. After briefly venturing into real estate, and having half of his business destroyed by Hurricane Katrina, he moved to Atlanta and founded ShapeMed.

ShapeMed is a medical wellness center with a concentration in aesthetic medicine and non-surgical comprehensive weight loss solutions. Under the leadership of Dr. Mark McKenna, the state of the art center has successfully qualified for Allergan Inc.’s Black Diamond Certification. Their recognition planes them on the list with some of the most respected providers of aesthetic treatments in the industry. His most recent business venture, OVME, launched in July 2017. The direct-to-consumer model allows consumers and prospective clients to connect with retail boutiques who offer high quality minimally invasive aesthetic services. Since their launch, Dr. McKenna has raised more than $3 million in funding for the new platform.

Dr. Mark McKenna attributes much of his success to the visualization of his goals and active meditation. Aside from his contributions in the world of aesthetic medicine, he is committed to giving back to his community. He is passionate about overall health and wellness, and along with OVME, has entered into a charitable partnership with the Make A Wish Foundation.

While he was the founder of several successful businesses, in 2014 he went back to school and earned an online executive MBA in entrepreneurship. Although the program proved to be difficult, Dr. McKenna admits that he felt better prepared to launch his most recent venture after graduation.

Dr. Mark McKenna is also a member of the Entrepreneur’s Organization, and a previous member of the New Orleans Jazz Festival and the New Orleans Industrial Board.

Eric Lefkofsky Ambitious and Serial Entrepreneur and a Passionate Philanthropist

Eric Lefkofsky is a well-established and successful businessman based in the United States and has a net worth of nearly $2.2 billion. He is a serial entrepreneur and has started many small and large businesses over a period, which includes Groupon, which is one of the most successful business ventures by Eric Lefkofsky and is currently valued at over $2 billion. Eric Lefkofsky is associated with many other sectors as well including medical technology, finance and investment, technology, and more. Eric Lefkofsky is also amongst the wealthiest philanthropists in the world and runs a family foundation by the name of Lefkofsky Family Foundation that supports many high impact social and community welfare initiatives, including for education, medical, social welfare, women empowerment, art and culture, and more.

Some of the companies co-owned by Eric Lefkofsky include Echo Global Logistics, InnerWorkings, Tempus, Groupon, MediaOcean, and Lightbank. The Lefkofsky Family Foundation started by Eric Lefkofsky aims to reach out to people in need across the globe and help disadvantaged people gain access to better education, health, and high impact social initiatives. Currently, Eric Lefkofksky is busy in expanding Tempus, which is a technology, based enterprise that collects molecular and clinical data from different medical facilities to help the physicians to decide upon the treatment course in a more precise manner. Such clinical data can help the doctors to decipher what treatment would be active on the patient, and which treatment method would be more useful in comparison to other treatment options available.

For long, the doctors have been working with lack of clinical and molecular data, which have forced them to approach every disease in a one-size-fits-all approach. However, as the genetic makeup of every individual is different, some medicines are effective on some people while being ineffective on others. It is to solve this puzzle that Eric Lefkofsky created Tempus. Eric Lefkofsky has pledged to invest $100 million in Tempus, and many other private venture capital firms have also agreed to invest in this initiative. It is expected to change the way cancer treatment is provided in the future entirely. Eric Lefkofsky believes that such aggregation of medical data is essential for the doctors to provide more accurate and efficient data.